Android app on Google Play

Roth Capital Starts Nektar Therapeutics (NKTR) at Buy

May 24, 2012 9:22 AM EDT Send to a Friend
Get Alerts NKTR Hot Sheet
Price: $10.97 --0%

Rating Summary:
    5 Buy, 2 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade NKTR Now!
Join SI Premium – FREE
Roth Capital initiates coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy. PT $10.00.

For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.

Shares of Nektar Therapeutics closed at $6.97 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment